Skip to content

LES PHARMACIES RURALES

Active
Public limited companyfounded 1991active for 35 yearsPlace de Velaines (VEL) 13, 7760 Celles (lez-Tournai), BelgiumKBO/BCE: BE 0444.082.628

From the official registers: KBO 33 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

The computed 12-month bankruptcy probability of LES PHARMACIES RURALES is 1.8% (moderate). The annual accounts of LES PHARMACIES RURALES for financial year 2025 show a net loss of 50% of the equity at the start of that year. The 2025 annual accounts show equity of €192,983 and a net result of -€193,612. Equity fluctuates too strongly from year to year to read a trend from it. Its solvency ranks better than 15% of 5,036 sector peers (NACE 47, financial year 2025). The company has been active since 1991 and the Belgian Official Gazette contains no insolvency or warning signals.

Overview

Official details

KBO
Status
Active since 06-05-1991 Normal situation
Activity
Retail sale of pharmaceutical products NACE 47730and 1 other
Establishment units
9 establishment units
Financial year end
31 December
Peppol
Reachable since 02-12-2025

Board and ownership

Financial position

52 Fair Checked score 2025
Bankruptcy probabilitywithin 12 months
1.8%
Annual accounts 2025
Gross margin
€1.5m
▲ 13.8%
Turnover
≈ €3.8m
estimated
Loss
€193,612
▼ 18.6%
Equity
€192,983
▼ 50.1%
Total assets
€5.9m
▼ 4.7%
Staff
19.6 FTE
▲ 10.1%
Filed on 30-09-2026, 61 days after the deadlineat the National Bank
Score breakdownraises riskEquity €192,983 (3.3% of total assets)Liquidity: current ratio 0.44, cash €241,179Last filed accounts filed 61 days late; 3 of the last 3 accounts lateSector: Retail trade (NACE 47)Show the evidence

Checked score

Score 2025
52 / 100
Fair
Probability in this band: 1.5% to 4.2%
Financially stronger than 14% of small companies in retail trade (NACE 47)
Financial strength · tick: 2024
Weak
Solvency 28-3
equity 3.3% of total assets
Liquidity 19+1
short-term debt 67.6% · cash 4.1%
Profitability 31+8
return on assets -3.3%
Bankruptcy probability within 12 months
1.8% Moderate
0%0.5%1.5%4%10%≥ 25%

About 2 in 100 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.4% (3,694 companies, NACE 47, small)
Last 24 months 12-2024: 3.1% 01-2025: 3.1%● unchanged vs 12-2024 02-2025: 4.4%▲ +1.3 percentage points vs 01-2025 03-2025: 4.1%▼ -0.3 percentage points vs 02-2025 04-2025: 4.1%● unchanged vs 03-2025 05-2025: 3.9%▼ -0.2 percentage points vs 04-2025 06-2025: 4.0%▲ +0.1 percentage points vs 05-2025 07-2025: 4.5%▲ +0.5 percentage points vs 06-2025 08-2025: 5.0%▲ +0.5 percentage points vs 07-2025 09-2025: 5.7%▲ +0.7 percentage points vs 08-2025 10-2025: 6.8%▲ +1.1 percentage points vs 09-2025highest value 11-2025: 2.5%▼ -4.3 percentage points vs 10-2025 12-2025: 2.5%● unchanged vs 11-2025 01-2026: 2.5%● unchanged vs 12-2025 02-2026: 2.5%● unchanged vs 01-2026 03-2026: 2.5%● unchanged vs 02-2026 04-2026: 2.5%● unchanged vs 03-2026 05-2026: 2.5%● unchanged vs 04-2026 06-2026: 2.6%▲ +0.1 percentage points vs 05-2026 07-2026: 2.6%● unchanged vs 06-2026 08-2026: 3.5%▲ +0.9 percentage points vs 07-2026 09-2026: 4.0%▲ +0.5 percentage points vs 08-2026 10-2026: 1.8%▼ -2.2 percentage points vs 09-2026lowest value 11-2026: 1.8%● unchanged vs 10-2026lowest value
Credit of up to €10,000 on 30-day terms, only on tighter conditions
Net loss of at least half of total assets or of the equity at the start of the financial year.
Liquidity is insufficient, with a current ratio of 0.44 (0.45 in 2024), below 1. Short-term debt is 67.6% and cash 4.1% of total assets. 96.7% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, small). It does better than 14% of them on solvency, 17% on liquidity, 17% on profitability and 8% on growth.

The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Seven signals.
raises risk
raises risk · Equity €192,983 (3.3% of total assets)
NBB · annual accounts
raises risk · Liquidity: current ratio 0.44, cash €241,179
NBB · annual accounts
raises risk · Last filed accounts filed 61 days late; 3 of the last 3 accounts late
NBB · filings
raises risk · Sector: Retail trade (NACE 47)
KBO
raises risk · Persistent losses
Two consecutive loss-making years (2024 and 2025); equity is also lower. May indicate structural pressure on profitability.
NBB · annual accounts 2025
Net result per financial year
19202122232425
2019 to 2025 · latest year -€193,612
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 15% of 5036 sector peers (2025).
NBB · sector comparison
Position among 5036 sector peers
Solvency
better than 15%
← weakest strongest →
raises risk · 2025 accounts filed 61 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-09-2026, 61 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filings
Deviation from the deadline
2025
61 days late
2024
71 days late
2023
191 days late
2022
31 days late
2021
25 days late
2020
26 days late
2019
on the day
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 58 days after the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 10 October (3 of the last 3 accounts filed within 121 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Risk: 3 loss-making years in a rowloss in financial year 2025 -€193,612 View
  • Caution: Lower net result than 92% of companies in retail tradesector median €39,952 · 5,035 companies -€193,612 View
  • Caution: Equity fell in 2025from €386,595 to €192,983 ▼ 50.1% View
  • Heads a groupcompanies controlled 3 View

Companies linked to LES PHARMACIES RURALES

Comparable companies

These companies have the same main activity as LES PHARMACIES RURALES: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €3.2m and €6.6m, founded between 1969 and 2002.

CompanyTotal assetsGross margin
LES PHARMACIES RURALES Celles (lez-Tournai)€5.9m€1.5m
APOTHEEK LAMOOT Ieper€4.6m€1.8m
UNIDOSE PHARMA Izegem€3.9m€1.7m
Superphar Namur€6.6m€1.3m
DERMATHEEK Ranst€5.4m€2.3m
PHARMACIE ANSELME Antoing€4.8m€1.9m
OFFIPLANT Lessines€3.2m€1.3m
Full comparison

Documents

Annual accounts at the NBB

All 33 annual accounts

Articles and registers

Key facts about LES PHARMACIES RURALES

What is the company number of LES PHARMACIES RURALES?
The company number of LES PHARMACIES RURALES is 0444.082.628. The VAT number is the same number with BE in front: BE 0444.082.628.
Where is LES PHARMACIES RURALES based?
The registered office is at Place de Velaines (VEL) 13, 7760 Celles (lez-Tournai).Company details
What does LES PHARMACIES RURALES do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of LES PHARMACIES RURALES?
The legal form of LES PHARMACIES RURALES is Public limited company (NV).
When was LES PHARMACIES RURALES founded?
LES PHARMACIES RURALES was founded on 06-05-1991.
Is LES PHARMACIES RURALES still active?
Yes, LES PHARMACIES RURALES is an active enterprise in the KBO register.
How many employees does LES PHARMACIES RURALES have?
LES PHARMACIES RURALES had an average of 19.6 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of LES PHARMACIES RURALES?
The turnover in financial year 2025 is ≈ €3.8m. This figure is estimated from the gross margin of €1.5m and 30 comparable companies (NACE 477). It probably lies between €2.9m and €5.5m. In financial year 2020 turnover was €6.3m.
Is LES PHARMACIES RURALES profitable?
In financial year 2025, LES PHARMACIES RURALES made a loss of €193,612.
Where can I find the annual accounts of LES PHARMACIES RURALES?
LES PHARMACIES RURALES filed 33 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
When are the next annual accounts of LES PHARMACIES RURALES due?
LES PHARMACIES RURALES must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.